Your browser doesn't support javascript.
loading
Editorial commentary on "Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo".
Yamanishi, Tomonori; Kamasasko, Tomohiko; Kaga, Kanya; Fuse, Miki.
Affiliation
  • Yamanishi T; Department of Urology, Continence Center, Dokkyo Medical University, Tochigi, Japan.
  • Kamasasko T; Department of Urology, Continence Center, Dokkyo Medical University, Tochigi, Japan.
  • Kaga K; Department of Urology, Continence Center, Dokkyo Medical University, Tochigi, Japan.
  • Fuse M; Department of Urology, Continence Center, Dokkyo Medical University, Tochigi, Japan.
Transl Androl Urol ; 9(3): 1009-1012, 2020 Jun.
Article in En | MEDLINE | ID: mdl-32676385
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Transl Androl Urol Year: 2020 Document type: Article Affiliation country: Japan Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Transl Androl Urol Year: 2020 Document type: Article Affiliation country: Japan Country of publication: China